LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Centene Corp

Closed

Sector Healthcare

70.89 -2.37

Overview

Share price change

24h

Current

Min

70.73

Max

73.07

Key metrics

By Trading Economics

Income

-17M

1.1B

Sales

-570M

40B

P/E

Sector Avg

13.08

103.001

EPS

2.42

Profit margin

2.877

Employees

67,700

EBITDA

39M

2B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+18.25 upside

Dividends

By Dow Jones

Next Earnings

25 Oct 2024

Market Stats

By TradingEconomics

Market Cap

42B

Previous open

73.26

Previous close

70.89

News Sentiment

By Acuity

100%

0%

340 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Centene Corp Chart

Related News

25 Jul 2024, 11:00 UTC

Top News

Medicaid Was a Boon to Insurers During the Pandemic. Now, Not So Much. -- Heard on the Street -- WSJ

17 Jul 2024, 13:00 UTC

Top News

Would Trump Ease Up on Medicare? Wall Street Thinks So -- Heard on the Street -- WSJ

29 May 2024, 18:00 UTC

Top News

It's Not Just Medicare. Now Medicaid Is Giving Insurance Companies a Headache. -- WSJ

16 Apr 2024, 10:54 UTC

Earnings

UnitedHealth Earnings Beat -- With An Asterisk -- After Cyberattack; UNH Stock Rises -- IBD

2 Apr 2024, 14:00 UTC

Top News

Medicare Keeps Getting Tougher for Health Insurers -- Heard on the Street - Update

2 Apr 2024, 12:00 UTC

Top News

Medicare Keeps Getting Tougher for Health Insurers -- Heard on the Street -- WSJ

11 Feb 2024, 13:00 UTC

Top News

Your Medicare Plan Might Not Include as Many Freebies Next Year -- Heard on the Street -- WSJ

25 Jan 2024, 15:06 UTC

Top News

It Is Going to Be a Bad Year (or More) for the Medicare Business -- Heard on the Street -- WSJ

25 Jan 2024, 12:03 UTC

Earnings

Humana Dives On Huge 2024 Earnings Warning -- IBD

12 Jan 2024, 15:02 UTC

Earnings

Health-Insurer Stocks Drop on UnitedHealth's Earnings Report -- WSJ

Peer Comparison

Price change

Centene Corp Forecast

Price Target

By TipRanks

18.25% upside

12 Months Forecast

Average 85.92 USD  18.25%

High 97 USD

Low 69 USD

Based on 14 Wall Street analysts offering 12 month price targets forCentene Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

8

Buy

6

Hold

0

Sell

Technical Score

By Trading Central

N/A / 78.21Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

340 / 365 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Centene Corp

Centene Corporation is a multi-national healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It also provides education and outreach programs to inform and assist members in accessing appropriate healthcare services. It operates through two segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through government subsidized and commercial programs. Its Specialty Services segment includes companies offering diversified healthcare services and products to its Managed Care segment and other external customers. It provides a range of healthcare products and services, primarily through Medicaid, Medicare and commercial products.